Teladoc Inc Overview
TDOC was traded at $6.8600 as of 2025-06-13.
Teladoc Inc (TDOC)
Quarterly Financials
Annual Financials
Asset Type: Common Stock
Sector: LIFE SCIENCES
Industry: SERVICES-OFFICES & CLINICS OF DOCTORS OF MEDICINE
Description: Teladoc Health, Inc. provides business-to-business virtual health care services in the United States and internationally. The company is headquartered in Purchase, New York.
Address: 2 MANHATTANVILLE ROAD, SUITE 203, PURCHASE, NY, US
CIK: 1477449
Exchange: NYSE
Currency: USD
Country: USA
Fiscal Year End: December
Latest Quarter: June 30, 2024
Market Capitalization: 1,510,143,000
EBITDA: 65,961,000
PE Ratio: 0.00
PEG Ratio: -1.010
Book Value: 8.78
Dividend Per Share: 0.00
Dividend Yield: 0.0000
EPS: -5.96
Revenue Per Share (TTM): 15.60
Profit Margin: -0.385
Operating Margin (TTM): -0.077
Return on Assets (TTM): -0.034
Return on Equity (TTM): -0.530
Revenue (TTM): 2,609,340,000
Gross Profit (TTM): 1,662,853,000
Diluted EPS (TTM): -5.96
Quarterly Earnings Growth (YOY): 0.000
Quarterly Revenue Growth (YOY): -0.015
Analyst Target Price: 9.95
Analyst Ratings (Strong Buy): 1
Analyst Ratings (Buy): 5
Analyst Ratings (Hold): 23
Analyst Ratings (Sell): 0
Analyst Ratings (Strong Sell): 0
Trailing PE: 0.00
Forward PE: 357.14
Price to Sales Ratio (TTM): 0.579
Price to Book Ratio: 1.01
EV to Revenue: 0.742
EV to EBITDA: 12.16
Beta: 0.895
52 Week High: 22.54
52 Week Low: 6.76
50 Day Moving Average: 8.05
200 Day Moving Average: 13.51
Shares Outstanding: 171,218,000
Dividend Date: None
Ex-Dividend Date: None
Official Website: https://www.teladochealth.com
Financial Analysis
Valuation Overview
The company's Price-to-Earnings (P/E) ratio is N/A, with a forward P/E of 357.14. This suggests stable or moderated growth expectations. The Price-to-Book ratio of 1.01 indicates a premium valuation relative to its assets.
Profitability Metrics
With a profit margin of -0.385% and an operating margin of -0.077%, the company demonstrates challenged profitability. The Return on Equity (ROE) of -0.530% reflects its efficiency in generating returns for shareholders.
Growth Trends
Quarterly revenue growth (YOY) stands at -0.015%, and quarterly earnings growth (YOY) is N/A%. These figures indicate potential challenges in revenue expansion. The PEG ratio of -1.010 suggests growth at a reasonable price.
Dividend Profile
The company offers a dividend yield of N/A% with an annual dividend per share of $N/A. This makes it less appealing for income-focused investors.
Market Position
Trading at $6.8600 (within a 52-week range of $6.76 to $22.54), the stock's beta of 0.895 indicates lower volatility compared to the market. Analyst target price is $9.95, suggesting limited near-term growth.